Results of liver biopsy among 437 eligible patients (ALT or AST >1.5 times of normal) consisted of steatosis (42%), osteohepatitis (58%), fibrosis (27%), cirrhosis (15.4%), and hepatocellular carcinoma (0.7%) [43]. This evidence concerns the gene GPT and hepatocellular carcinoma.